Prognosis

MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer

H. C. Zhuo, Song, Y. F., Ye, J., Lai, G. X., and Liu, D. L., MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer, vol. 15, p. -, 2016.

MicroRNA-154 (miR-154) is dysregulated in some human malignancies and is correlated with tumor progression. However, its expression and function in non-small cell lung cancer (NSCLC) remain unclear. Therefore, we explored the effects of miR-154 on NSCLC tumorigenesis and development. Using quantitative reverse transcription-polymerase chain reaction, we detected miR-154 expression in NSCLC cell lines and primary tumor tissues.

Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer

L. Zhang, Yang, W. P., Wu, L. Y., Zhu, X., Wei, C. Y., Zhang, L., Yang, W. P., Wu, L. Y., Zhu, X., and Wei, C. Y., Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer, vol. 15, p. -, 2016.

Our objective was to explore the expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 (Keap1) in breast cancer tissue. Eighty-one breast cancer patients having undergone surgical treatment in our hospital between March 2002 and December 2008 were enrolled in this study. Normal tissue adjacent to tumors was used for the control samples. Diagnoses for all patients were confirmed by postoperative pathological examination.

Association between the expression of HIF-1α and VEGF and prognostic implications in primary liver cancer

L. Y. Guo, Zhu, P., Jin, X. P., Guo, L. Y., Zhu, P., and Jin, X. P., Association between the expression of HIF-1α and VEGF and prognostic implications in primary liver cancer, vol. 15, p. -, 2016.

The goal of this study was to investigate the expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in primary liver cancer (PLC) and their association with prognosis. Tumor tissue, non-tumor tissue, and blood samples of 75 PLC patients were collected. Blood samples of 20 volunteers were also collected as healthy controls. Real-time quantitative reverse transcription-polymerase chain reaction was used to analyze the mRNA levels of HIF-1α and VEGF in the tissues. Protein expression of HIF-1α and VEGF was analyzed by immunohistochemistry.

Association of Beclin-1 and microRNA-30a expression with the severity and treatment response of colorectal cancer

L. Liu, Meng, T., Wang, Q. S., Jin, H. Z., Sun, Z. Q., Jin, B., Fang, F., Wang, H. J., Liu, L., Meng, T., Wang, Q. S., Jin, H. Z., Sun, Z. Q., Jin, B., Fang, F., Wang, H. J., Liu, L., Meng, T., Wang, Q. S., Jin, H. Z., Sun, Z. Q., Jin, B., Fang, F., and Wang, H. J., Association of Beclin-1 and microRNA-30a expression with the severity and treatment response of colorectal cancer, vol. 15, p. -, 2016.

We investigated the associations between Beclin-1 and microRNA-30a (miR-30a) expression and the severity and treatment response in colorectal cancer (CRC). Our sample size consisted of 139 CRC patients who were treated with surgery alone. Immunohistochemistry was used to investigate the expression and prognostic significance of Beclin-1 in CRC, while the weak expression of Beclin-1 in normal tissue was used as the basis for assessing tumors (control group). Real-time reverse transcription-polymerase chain reaction quantified miR-30a levels.

Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer

X. Chen, Liu, X. S., Liu, H. Y., Lu, Y. Y., Li, Y., Chen, X., Liu, X. S., Liu, H. Y., Lu, Y. Y., Li, Y., Chen, X., Liu, X. S., Liu, H. Y., Lu, Y. Y., and Li, Y., Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer, vol. 15, p. -, 2016.

Deregulation of microRNAs (miRNAs) is implicated in the initiation and progression of gastric cancer (GC). Previous studies have demonstrated that miR-204 was downregulated in GC tissues. However, its expression profile in serum samples and its potential for clinical value remain unknown. Real-time PCR was performed to evaluate the expression level of serum miR-204 in patients with GC. The association between serum miR-204 expression level and the clinical outcome of GC was then investigated.

Subscribe to Prognosis